Cargando…
Editorial: Muscular dystrophies: Current therapeutic advances to improve and restore muscle homeostasis
Autores principales: | Bargiela, Ariadna, Hernández-Torres, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471546/ https://www.ncbi.nlm.nih.gov/pubmed/36120590 http://dx.doi.org/10.3389/fcell.2022.1009439 |
Ejemplares similares
-
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
por: Yao, Shanshan, et al.
Publicado: (2021) -
Gpr18 agonist dampens inflammation, enhances myogenesis, and restores muscle function in models of Duchenne muscular dystrophy
por: Dort, Junio, et al.
Publicado: (2023) -
Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
por: Ogura, Yuji, et al.
Publicado: (2014) -
Characterization of cardiac involvement in children with LMNA-related muscular dystrophy
por: Cesar, Sergi, et al.
Publicado: (2023) -
Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels
por: Barthélémy, Florian, et al.
Publicado: (2022)